These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 17079237
1. Minocycline delays but does not attenuate the course of experimental autoimmune encephalomyelitis in Streptococcus pneumoniae-infected mice. Herrmann I, Kellert M, Spreer A, Gerber J, Eiffert H, Prinz M, Nau R. J Antimicrob Chemother; 2007 Jan; 59(1):74-9. PubMed ID: 17079237 [Abstract] [Full Text] [Related]
3. Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice. Chen X, Hu X, Zou Y, Pi R, Liu M, Wang T, Zheng X, Liu M, Lin M, Liu P, Tao L. J Neuroimmunol; 2009 May 29; 210(1-2):22-9. PubMed ID: 19344957 [Abstract] [Full Text] [Related]
6. Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis. Spreer A, Lugert R, Stoltefaut V, Hoecht A, Eiffert H, Nau R. Crit Care Med; 2009 Jul 29; 37(7):2253-8. PubMed ID: 19487938 [Abstract] [Full Text] [Related]
7. Streptococcus pneumoniae Infection aggravates experimental autoimmune encephalomyelitis via Toll-like receptor 2. Herrmann I, Kellert M, Schmidt H, Mildner A, Hanisch UK, Brück W, Prinz M, Nau R. Infect Immun; 2006 Aug 29; 74(8):4841-8. PubMed ID: 16861672 [Abstract] [Full Text] [Related]
9. Additive effect of the combination of glatiramer acetate and minocycline in a model of MS. Giuliani F, Metz LM, Wilson T, Fan Y, Bar-Or A, Yong VW. J Neuroimmunol; 2005 Jan 29; 158(1-2):213-21. PubMed ID: 15589056 [Abstract] [Full Text] [Related]
16. Synergistic antimicrobial effect of cefotaxime and minocycline on proinflammatory cytokine levels in a murine model of Vibrio vulnificus infection. Chiang SR, Tang HJ, Chang PC, Cheng KC, Ko WC, Chen CH, Chuang YC. J Microbiol Immunol Infect; 2007 Apr 15; 40(2):123-33. PubMed ID: 17446960 [Abstract] [Full Text] [Related]
17. Ceftriaxone pharmacokinetics in interleukin-10-treated murine pneumococcal pneumonia. Wang E, Bergeron Y, Bergeron MG. J Antimicrob Chemother; 2005 May 15; 55(5):721-6. PubMed ID: 15772139 [Abstract] [Full Text] [Related]
18. Release of teichoic and lipoteichoic acids from 30 different strains of Streptococcus pneumoniae during exposure to ceftriaxone, meropenem, quinupristin/dalfopristin, rifampicin and trovafloxacin. Heer C, Stuertz K, Reinert RR, Mäder M, Nau R. Infection; 2000 May 15; 28(1):13-20. PubMed ID: 10697785 [Abstract] [Full Text] [Related]
19. Minimizing the release of proinflammatory and toxic bacterial products within the host: a promising approach to improve outcome in life-threatening infections. Nau R, Eiffert H. FEMS Immunol Med Microbiol; 2005 Apr 01; 44(1):1-16. PubMed ID: 15780573 [Abstract] [Full Text] [Related]